Skip to content

Inspection Record

FinVector Oy — FDA 483 Findings

US FDAInspected 2024-05-28Published 2026-10-20 5 findingsOther quality systemMaterial and supplier controlEquipment and facilityQuality unit oversight

Inspectors Gene D Arcy · Lewis K AntwiThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

2Material and supplier control

Establishment of the reliability of the container and closure supplier's report of analyses is deficient in that the test results are not appropriately validated at appropriate intervals.

3Equipment and facility

Written procedures for cleaning and maintenance fail to include maintenance and cleaning schedules.

4Other quality system

Your firm has not adequately validated your adherent (b) (4) regarding cell infection in that certain combinations of critical parameters have not been assessed.

5Quality unit oversight

The quality control unit lacks responsibility to approve all procedures or specifications impacting on the identity, strength, quality and purity of drug products.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

FinVector Oy findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.